Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Weight loss medications like Zepbound (tirzepatide) have become hugely popular throughout the United States
References [1] Judicial Panel on Multidistrict Litigation, December 2024 Order [2] PMC Article on Ozempic-Related Vision Loss [3] Endocrine Journal Study on Semaglutide and DVT Risk [4] CNBC Report on Novo Nordisk FDA Request [5] FDA Declaratory Order on Tirzepatide Shortage [6] Columbia Psychiatry News Report on GLP-1 Ethical Concerns
Studies (SURMONT-1) have demonstrated that participants lost up to 21 percent of their body weight using the 15 mg (milligram) dose once a week
Compounded versions from pharmacies like Belmar offer significant savings
The SURMOUNT-5 trial demonstrated superior weight loss with tirzepatide compared to semaglutide at 72 weeks
Nausea and appetite changes typically fade as the body's gastrointestinal system adjusts to the medication's mechanism of action
